This inventor holds 1 USPTO granted patent. Top assignee: Ventus Therapeutics U.s., Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Luke J Murphy in Pharmaceutical Chemistry
Introduction
Luke J Murphy is an accomplished inventor based in Dartmouth, CA. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. His work focuses on creating solid-state forms of compounds that can be used in the treatment of various disorders.
Latest Patents
Luke J Murphy holds a patent for "Solid freebase forms of 5-chloro-2-(4-((2-hydroxy-2-methylpropyl)amino)pyrido[3,4-d]pyridazin-1-yl)phenol for inhibiting NLRP3 and uses thereof." This patent describes solid-state forms of Compound 1 freebase, along with processes for their preparation and pharmaceutical compositions that include these forms. The applications of this invention are particularly relevant in the treatment and prevention of disorders associated with NLRP3 activity.
Career Highlights
Luke J Murphy is currently associated with Ventus Therapeutics U.S., Inc., where he continues to advance his research and development efforts. His expertise in pharmaceutical formulations has positioned him as a key player in the industry, contributing to the development of innovative therapies.
Collaborations
(Section skipped due to space constraints.)
Conclusion
Luke J Murphy's contributions to pharmaceutical chemistry through his innovative patents and work at Ventus Therapeutics U.S., Inc. highlight his role as a significant inventor in the field. His research continues to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile